Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

128.08
BATS BZX Real-Time Price
As of 3:20pm ET
 +2.98 / +2.38%
Today’s Change
110.90
Today|||52-Week Range
169.89
-10.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$5.6B

Company Description

United Therapeutics Corp. engages in the development and commercialization of innovative products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension, high-risk neuroblastoma. It is also involved in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Contact Information

United Therapeutics Corp.
1040 Spring Street
Silver Spring Maryland 20910
P:(301) 608-9292
Investor Relations:

Employees

Shareholders

Other institutional57.23%
Mutual fund holders50.83%
Individual stakeholders13.64%

Top Executives

Martine A. RothblattChairman & Chief Executive Officer
Michael BenkowitzPresident & Chief Operating Officer
James Christopher EdgemondCFO, Treasurer & Principal Accounting Officer
Paul A. MahonSecretary, EVP & General Counsel